Skip to Content

93 5721 (Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base))

Pill imprint 93 5721 has been identified as Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base).

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) 93 5721
Discount Card Promo
Buprenorphine hydrochloride and naloxone hydrochloride (sublingual)
Imprint:
93 5721
Strength:
8 mg (base) / 2 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Teva Pharmaceuticals USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide